argenx SE | Investor Conference Presentation Deck | 22 slides

argenx · 2023-01
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

22
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · What Is
02
other
Open slide detailBeat · What Is
03
front_matter
Open slide detailBeat · What Is
04
The slide uses a circular graphic to emphasize the 'revolution' in autoimmunity.present_solution
Open slide detailBeat · What IsLoop · Aha Moment
05
The slide uses a circular graphic featuring patient photos to emphasize the human-centric approach.present_solution
Open slide detailBeat · What IsLoop · Golden Circle
06
The slide uses a four-circle cluster diagram to represent strategic pillars.summarize
Open slide detailBeat · What Is
07
The slide uses a bar chart to show quarterly revenue growth and callout boxes to highlight operational and market access milestones.analyze_data
Open slide detailBeat · What Is
08
The slide uses two line charts to show efficacy metrics (IgG reduction and platelet count) and lists four medical/scientific publication sources at the bottom.summarize
Open slide detailBeat · What Could Be
09
Includes a 3-step mechanism of action diagram.summarize
Open slide detailBeat · What Could Be
10
The diagram uses a four-circle overlapping layout to represent strategic pillars.summarize
Open slide detailBeat · What Could Be
11
The slide uses a hub-and-spoke style diagram to organize strategic pillars.present_solution
Open slide detailBeat · What Could Be
12
The slide uses a hub-and-spoke visual metaphor to connect the clinical class of medicines to a list of specific autoantibody targets.establish_context
Open slide detailBeat · What Could Be
13
The slide uses a pyramid structure to represent market size by patient population, with larger populations at the base.size_opportunity
Open slide detailBeat · What Could Be
14
The slide uses a horizontal timeline structure with vertical segmentation by development stage. Patient numbers represent U.S. prevalence.plan_implementation
Open slide detailBeat · What Could Be
15
The slide highlights the mechanism of action (pH/Ca2+ switch, no effector function, optimal recycling) and the clinical pipeline status for MMN, delayed graft fpresent_solution
Open slide detailBeat · New BlissLoop · Before After
16
The slide uses immunofluorescence microscopy to show structural damage and bar charts/traces to show functional respiratory recovery.analyze_data
Open slide detailBeat · New Bliss
17
Includes a biological mechanism diagram on the left and a clinical trial design timeline/process on the right.present_framework
Open slide detailBeat · New Bliss
18
The slide uses a series of four circular icons atop vertical color-coded columns to categorize medical indications by therapeutic area.present_framework
Open slide detailBeat · New Bliss
19
The slide uses a hub-and-spoke style layout to show relationships between entities.establish_context
Open slide detailBeat · New Bliss
20
The slide uses a dual-section layout separating commercial and clinical activities, with specific dates aligned to each milestone.plan_implementation
Open slide detailBeat · New Bliss
21
The diagram features five core values: Co-Creation, Empowerment, Excellence, Humility, and Innovation.other
Open slide detailBeat · New Bliss
22
The chart uses a horizontal bar format to represent clinical trial progress from Preclinical to Commercial stages.plan_implementation
Open slide detailBeat · New Bliss